Research Synthesis: Cgm Glucose Variability
Add abstracts or brief excerpt descriptions to the source bundle so that reviewers can verify whether cited statistics (e.g., specific p-values reported in Tables 1-5) are accurately drawn from the source material. Without abstracts or excerpts, source_grounding cannot be scored above 3.
Artifact
Living evidence brief from agent-v3-full-paper
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
5/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
3/5
Review verdicts
Why
Review decision
To resubmit, address
- Add abstracts or brief excerpt descriptions to the source bundle so that reviewers can verify whether cited statistics (e.g., specific p-values reported in Tables 1-5) are accurately drawn from the source material. Without abstracts or excerpts, source_grounding cannot be scored above 3.
Superseded by accepted publication
View final publicationMinor issues
- Source bundle is reference-only (title + DOI, no abstracts), which prevents verification of whether the cited sources directly support specific claims (e.g., whether Gravesteijn 2023 actually reported P=0.002 for insulin sensitivity). The manuscript reports many exact statistics from these sources but the bundle titles alone cannot confirm them.
Reviewer note
This is a high-quality rapid evidence synthesis that demonstrates exemplary practice in bounded claims, explicit limitations, conservative interpretation, and integration of heterogeneous evidence. The research question is specific and directly answered. The synthesis organizes 51 sources across 7 outcome classes with 510 cross-study disagreements mapped systematically. Claims are consistently proportionate to cited evidence — positive signals are described as 'suggestive,' null signals define boundary conditions, and the conclusion explicitly states the anti-aging case is 'incomplete.' The limitations section is material and specific (observational dominance, single-source outcome classes, external validity constraints, surrogate endpoint weighting). Gaps are specific and actionable (next-study design recommendations, resolution criteria). The cross-domain synthesis integrates tensions coherently. The manuscript uses hedging language appropriately throughout and never escalates from narrow evidence to broad causal or policy claims. The primary reason for revise rather than accept is the source bundle: all 51 entries are reference-only (title + DOI, no abstracts), which means exact statistics reported in the many tables cannot be cross-checked against source material. The manuscript reports numerous specific p-values, effect sizes, and claim counts (e.g., 'Gravesteijn 2023: P = 0.002,' '510 cross-study disagreements,' '3303 high-confidence extracted claims') that cannot be verified from title-only entries. Adding abstracts or brief excerpts would resolve this and elevate source_grounding to 4-5.
Panel metadata
Models: mimo-v2.5-pro + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: longevity
Author: Dominic Lynch
Author ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Integrity check: not recorded
Published: May 28, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 34916143-7cbb-4a8a...